HomeOpen Access NewsHealth & Social Care

Health & Social Care

Could you have an iodine deficiency?

Iodine deficiency in the UK is generally accepted as a health problem from the past, but recent research suggests this may not be the...

HealthTracker™ for patients, clinician & researchers

Professor Paramala Santosh, CEO of HealthTracker Ltd, co-developed the HealthTrackerTM platform – developed by clinicians, assisted by patients for patients, clinicians & researchers, more of which we learn about here.

How can touch-free technology help the NHS?

Here, Videx UK highlights how innovative hands-free door entry can help services return to normalcy post-COVID-19.

A healthcare system for the 21st century

Ben Howlett, Managing Director at Public Policy Projects, discusses why we must invest in technology to enable our healthcare systems to reform, and the role of technology in facilitating collaboration between service providers.

Data shows 49% of Black British adults want COVID vaccine

ONS data from January shows that only 49% of Black British adults would take the COVID vaccine - the UK Government acknowledges that others are wary about the intention of "some institutions and authorities".

Data finds 36% of people refuse COVID vaccine due to side effect fears

According to new ONS data, 36% of UK people who are vaccine hesitant have strong side effect fears - while a further 12% fear needles, and 22% think vaccines could impact fertility.

New Zealand creates paid miscarriage leave of three days

The historic legislation will give mothers and parents three days of paid miscarriage leave, which will also apply to those dealing with a stillbirth.

Improving staff satisfaction during a global pandemic

Lesley Youren, Hospital Segment Marketing Manager at Draeger Medical UK, talks about creating care-centred workplaces and improving staff satisfaction during a global pandemic.

Zebra Technologies: Dedicated to improving global health

We spoke with Tony Cecchin, Vice President and General Manager of Global Supplies at Zebra Technologies and President of Temptime Corporation, and Chris Caulfield, Vice President of Temptime Operations about their work supporting front-line workers and easing the shipment of medical products through the supply chain.

Advancing research on human milk and infant nutrition

Dr Andrew Bremer, Paediatric Endocrinologist and Chief of the Pediatric Growth and Nutrition Branch at the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) part of the U.S. National Institutes of Health, discusses NICHD-supported research on human milk and infant nutrition.

Scientists reveal that tinnitus is possible COVID-19 symptom  

The University of Manchester found that tinnitus could be a COVID-19 symptom - some patients of the virus are reporting a loss in hearing and ringing of the ears.

Dexamethasone steroid saved one million people from COVID death

The Dexamethasone steroid has been used across the globe to help treat COVID-19 in the ICU - leading to atleast one million survivors of hospitalisation from the virus.

How can we protect people from air pollution?

Sarah Woolnough, Chief Executive of Asthma UK and the British Lung Foundation, discusses the UK’s toxic air crisis, the invisible threat of air pollution, and outlines how policymakers must protect people’s health and create a fairer, healthier society.

Poll finds 61% of people in France think AstraZeneca vaccine is unsafe

According to a new YouGov poll, 61% of people in France now believe that the AstraZeneca vaccine is unsafe, with Germany following closely at 55% - creating fears about the potential impact of vaccine hesitancy on the rollout.

European Medicines Agency say AstraZeneca does not cause blood clots

The safety committee of the European Medicines Agency said the investigation did not prove that AstraZeneca vaccinations cause blood clots - describing the possibility as an "extremely small likelihood".

Vaccine shortage in UK means under-50s to wait longer for first dose

The NHS released new information explaining that there would be a vaccine shortage in the UK from 29 March, meaning under-50s will wait longer for their first jab as second doses are given to the most vulnerable cohorts.

The journey to building a patient neuro rehabilitation platform

L2S2 Marketing Manager Max McKiernan details the journey that led Neuro ProActive Founder, Ian Pearce, to start the development of a digital neuro rehabilitation platform.

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders